Neuronetics (Malvern, PA) a commercial-stage medical device company focused on transcranial magnetic neuromodulation for psychiatric and neurological disorders, closed a $36M Series D financing. Participants include New Leaf Venture Partners, Investor Growth Capital, Quaker BioVentures, Three Arch Partners, Onset Ventures, Interwest Partners and KBL Healthcare Ventures.